1. ONUSIDA (2023) Fiche d’information. Dernières statistiques sur l’état de l’épidémie de sida. https://www.unaids.org/fr/resources/fact-sheet
2. WHO (2021) HIV Drug Resistance Report. https://www.who.int/publications-detail-redirect/9789240038608
3. WHO (2016) World Health Organization: Consolidated guidelines. Genève. https://scholar.google.com/scholar_lookup?title=Consolidated+guidelines+on+the+use+of+antiretroviral+drugs+for+treating+and+preventing+HIV+infection.+Recommendations+for+a+public+health+approach+-+Second+edition.+2nd+ed&publication_year=2018&
4. Dechi, J.J.R., Toni, T.D., Cisse-Camara, M., Philippe, N.J.L., Ake, A.J.A., Siransy, K.L., et al. (2022) Nucleoside Reverse Transcriptase Inhibitors Resistance in Children and Adults with Virological Failure in a Context of Systematic Switching to a Dolutegravir-Based Combination. Biochemistry and Molecular Biology, 7, 70-74.
5. Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy